Evaluating the Quality and Readability of Information Provided by Generative Artificial Intelligence Chatbots on Clavicle Fracture Treatment Options

评估生成式人工智能聊天机器人提供的关于锁骨骨折治疗方案的信息的质量和可读性

阅读:1

Abstract

Introduction Generative artificial intelligence (AI) chatbots, like ChatGPT, have become more competent and prevalent, making their role in patient education more salient. This study aimed to compare the educational utility of six AI chatbots by quantifying the readability and quality of their answers to common patient questions about clavicle fracture management. Methods ChatGPT 4, ChatGPT 4o, Gemini 1.0, Gemini 1.5 Pro, Microsoft Copilot, and Perplexity were used with no prior training. Ten representative patient questions about clavicle fractures were posed to each model. The readability of AI responses was measured using Flesch-Kincaid Reading Grade Level, Gunning Fog, and Simple Measure of Gobbledygook (SMOG). Six orthopedists blindly graded the response quality of each model using the DISCERN criteria. Both metrics were analyzed via the Kruskal-Wallis test. Results No statistically significant difference was found among the readability of the six models. Microsoft Copilot (70.33±7.74) and Perplexity (71.83±7.57) demonstrated statistically significant higher DISCERN scores than ChatGPT 4 (56.67±7.15) and Gemini 1.5 Pro (51.00±8.94) with similar findings seen between Gemini 1.0 (68.00±6.42) and Gemini 1.5 Pro. The mean overall quality (question 16, DISCERN) of each model was rated at or above average (range, 3-4.4). Conclusion The findings suggest generative AI models have the capability to serve as supplementary patient education materials. With equal readability and overall high quality, Microsoft Copilot and Perplexity may be implicated as chatbots with the most educational utility regarding surgical intervention for clavicle fractures.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。